ChemFeeds Site Navigation:
Journal Selection:
Search:

99) GRPR Photoacoustic Imaging Agent for Imaging Prostate Cancer (Clinical Cancer Research) Tuesday July 15th 2014


100) Mutational Analysis of Germ Cell Tumors (Clinical Cancer Research) Tuesday July 15th 2014


101) Diffusion-Weighted MRI in Prostate Cancer: Prediction of Aggressiveness (Clinical Cancer Research) Tuesday July 15th 2014


102) PAP DNA Vaccine Immune Monitoring in Patients with CRPC (Clinical Cancer Research) Tuesday July 15th 2014


103) Safety and Pharmacology of VTX-2337 (Clinical Cancer Research) Tuesday July 15th 2014


104) A Randomized Phase II Presurgical Trial of Transdermal Hydroxytamoxifen Gel versus Oral Tamoxifen (Clinical Cancer Research) Tuesday July 15th 2014


105) Racotumomab-Alum as Switch Maintenance Therapy in NSCLC (Clinical Cancer Research) Tuesday July 15th 2014


106) Immunotherapy for Brain Cancer (Clinical Cancer Research) Tuesday July 15th 2014


107) Senescence Resistance Driven by Inactivated p53 (Clinical Cancer Research) Tuesday July 15th 2014


108) At the Intersection of Fibrosis and Metastasis (Clinical Cancer Research) Tuesday July 15th 2014


109) Pertuzumab for Neoadjuvant Use in Breast Cancer (Clinical Cancer Research) Tuesday July 15th 2014


110) The Forgotten Poster Child (Clinical Cancer Research) Tuesday July 15th 2014


111) Looking Forward: An Update to the CCR Instructions for Authors (Clinical Cancer Research) Tuesday July 15th 2014


112) SNPs in PI3K-PTEN-mTOR and Brain Metastases in NSCLC--Response (Clinical Cancer Research) Tuesday July 1st 2014


113) SNPs in PI3K-PTEN-mTOR and Brain Metastases in NSCLC--Letter (Clinical Cancer Research) Tuesday July 1st 2014


114) Aromatase in Lung Adenocarcinomas with EGFR Mutations (Clinical Cancer Research) Tuesday July 1st 2014


115) Cediranib in Patients with Advanced GIST or STS (Clinical Cancer Research) Tuesday July 1st 2014


116) MDS/AML Stem Cells Express CD52 (Clinical Cancer Research) Tuesday July 1st 2014


117) LY2510924 in Patients with Advanced Cancer (Clinical Cancer Research) Tuesday July 1st 2014


118) TP53 in Breast Cancer (Clinical Cancer Research) Tuesday July 1st 2014


119) Variability in Assessing Response in Metastatic Colorectal Cancer (Clinical Cancer Research) Tuesday July 1st 2014


120) FDOPA PET Survival Predictions for Glioma (Clinical Cancer Research) Tuesday July 1st 2014


121) 18FDG PET-MRI of Breast Tumors: Feasibility (Clinical Cancer Research) Tuesday July 1st 2014


122) In vivo Fluorescence Lifetime Imaging for Monitoring the Cancer Treatment (Clinical Cancer Research) Tuesday July 1st 2014


123) Amoxapine Alleviates Cancer Drug Toxicity (Clinical Cancer Research) Tuesday July 1st 2014


124) PI3K/mTOR Inhibition and Trastuzumab Resistance (Clinical Cancer Research) Tuesday July 1st 2014


125) EGFR-ERCC1 Interaction Involvement in IR-Induced DNA Repair (Clinical Cancer Research) Tuesday July 1st 2014


126) Pam3CSK4 Increases Anticancer Effect of Ara-C (Clinical Cancer Research) Tuesday July 1st 2014


127) Regorafenib Kills Colon Cancer Cells through PUMA (Clinical Cancer Research) Tuesday July 1st 2014


128) BKM120 Activity in FDC-FL Cross-talk (Clinical Cancer Research) Tuesday July 1st 2014


129) PD-L1 in BRAF-Mutant, NRAS-Mutant, and Wild-Type Melanoma (Clinical Cancer Research) Tuesday July 1st 2014


130) Sirt7 Promotes Colorectal Cancer Tumorigenesis (Clinical Cancer Research) Tuesday July 1st 2014


131) Contact Guidance Controls T-cell Migration in PDAC (Clinical Cancer Research) Tuesday July 1st 2014


132) MET in Papillary RCC (Clinical Cancer Research) Tuesday July 1st 2014


133) Identification of T-cell Antigens by Minigene Screening (Clinical Cancer Research) Tuesday July 1st 2014


134) NK Infusions as Cancer Therapy (Clinical Cancer Research) Tuesday July 1st 2014


135) Niches in Metastatic Dormancy (Clinical Cancer Research) Tuesday July 1st 2014


136) CDK4 Inhibitors (Clinical Cancer Research) Tuesday July 1st 2014


137) Blocking and Randomization for Biomarker Discovery (Clinical Cancer Research) Tuesday July 1st 2014


138) FDA Clinical Investigator Inspections (Clinical Cancer Research) Tuesday July 1st 2014


139) MET in Papillary Renal Cell Carcinoma (Clinical Cancer Research) Tuesday July 1st 2014


140) Retraction: Molecular Analysis of Non-Small Cell Lung Cancer Identifies Subsets with Different Sensitivity to Insulin-like Growth Factor I Receptor Inhibition (Clinical Cancer Research) Friday June 13th 2014


141) Relative Lymphocyte Count as a Biomarker for Survival with Catumaxomab (Clinical Cancer Research) Friday June 13th 2014


142) miR-31-3p Expression and PFS in Patients with mCRC (Clinical Cancer Research) Friday June 13th 2014


143) Somatic Mutations and Clinical Outcome in Melanoma Samples (Clinical Cancer Research) Friday June 13th 2014


144) KRAS-LCS6 Polymorphism in Stage III Colon Cancer (Clinical Cancer Research) Friday June 13th 2014


145) Four-Gene Blood Panel Predicts Survival after Tremelimumab (Clinical Cancer Research) Friday June 13th 2014


146) FGFR1 Expression Predicts FGFR1-Dependent Lung Cancer (Clinical Cancer Research) Friday June 13th 2014


147) Erlotinib, Erlotinib-Sulindac versus Placebo in Operable HNSCC (Clinical Cancer Research) Friday June 13th 2014


148) Biomarkers of Residual Disease in Ovarian Cancer (Clinical Cancer Research) Friday June 13th 2014


149) SNPs Associated with the Prognosis of Stage I NSCLC (Clinical Cancer Research) Friday June 13th 2014


150) CHFR Methylation Predicts Prognosis in Colorectal Cancer (Clinical Cancer Research) Friday June 13th 2014


151) Initial FDG-PET/CT and Involved sFLC in Solitary Plasmacytoma (Clinical Cancer Research) Friday June 13th 2014


152) PET/MRI in Primary Prostate Cancer (Clinical Cancer Research) Friday June 13th 2014


153) Prognostic Markers of NMIBC (Clinical Cancer Research) Friday June 13th 2014


154) Chloroquine Inhibits Breast Cancer (Clinical Cancer Research) Friday June 13th 2014


155) Synthetic Lethality of PIM1 and PLK1 Inhibition (Clinical Cancer Research) Friday June 13th 2014


156) Niclosamide Overcomes Resistance to Enzalutamide (Clinical Cancer Research) Friday June 13th 2014


157) Anti-EGFR Radioimmunotherapy in Pancreatic Cancer (Clinical Cancer Research) Friday June 13th 2014


158) DUB Inhibitor RA-9 as Ovarian Cancer Therapy (Clinical Cancer Research) Friday June 13th 2014


159) Autophagy Inhibition Enhances Efficacy of Epirubicin in TNBC (Clinical Cancer Research) Friday June 13th 2014


160) Inhibition of RTKs and mTOR in MPNST (Clinical Cancer Research) Friday June 13th 2014


161) Everolimus Binds to and Inhibits Carboxylesterase (Clinical Cancer Research) Friday June 13th 2014


162) Hypomethylated and Induced Genes as Anticancer Drug Targets (Clinical Cancer Research) Friday June 13th 2014


163) MicroRNAs at 14q32 Are Prognostic in Lung Adenocarcinoma (Clinical Cancer Research) Friday June 13th 2014


164) GM-CSF in Colorectal Cancer (Clinical Cancer Research) Friday June 13th 2014


165) Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma (Clinical Cancer Research) Friday June 13th 2014


166) EZH2 Mutations in Follicular Lymphoma (Clinical Cancer Research) Friday June 13th 2014


167) Bone Metastasis and Muscle Weakness (Clinical Cancer Research) Friday June 13th 2014


168) Protein Turnover: New Targets for Cancer Treatment (Clinical Cancer Research) Friday June 13th 2014


169) PI3K Phosphatases in Prognosis and Therapy (Clinical Cancer Research) Friday June 13th 2014


170) New Strategies in Ewing Sarcoma (Clinical Cancer Research) Friday June 13th 2014


171) Manipulating the Epigenome in Germinal Center Lymphomas (Clinical Cancer Research) Friday June 13th 2014


172) Correction: Induction of Cell Cycle Arrest and Apoptosis by the Proteasome Inhibitor PS-341 in Hodgkin Disease Cell Lines Is Independent of Inhibitor of Nuclear Factor-{kappa}B Mutations or Activation of the CD30, CD40, and RANK Receptors (Clinical Cancer Research) Friday May 30th 2014


173) Prognostic Impact of Specific KRAS Mutations in Colon Cancer (Clinical Cancer Research) Friday May 30th 2014


174) ERK Pathway and Response to Cetuximab-Containing Therapy (Clinical Cancer Research) Friday May 30th 2014


175) Phase II Results of Dovitinib in Renal Cell Carcinoma (Clinical Cancer Research) Friday May 30th 2014


176) Adjuvant CIK Treatment of TNBC (Clinical Cancer Research) Friday May 30th 2014


177) miR-135b for Colorectal Cancer Diagnosis (Clinical Cancer Research) Friday May 30th 2014


178) Diffusion-Weighted MRI for Lymphoma Staging (Clinical Cancer Research) Friday May 30th 2014


179) Estrogen-Related Genes and Prostate Cancer Prognostic Stratification (Clinical Cancer Research) Friday May 30th 2014


180) Antitumor Activity of Cabozantinib in HCC (Clinical Cancer Research) Friday May 30th 2014


181) Ganitumab Inhibits IGF-II-Dependent Ovarian Cancer Models (Clinical Cancer Research) Friday May 30th 2014


182) Cetuximab Resistance and HRAS Oncogenic Mutations in HNSCC (Clinical Cancer Research) Friday May 30th 2014


183) Zoledronic Acid in the Pre- and Postmenopausal Setting (Clinical Cancer Research) Friday May 30th 2014


184) Chimeric HER2 Vaccines Overcome Cancer Patient's T-cell Dysfunction (Clinical Cancer Research) Friday May 30th 2014


185) Driver Mutations in IDH1-Mutant Gliomas (Clinical Cancer Research) Friday May 30th 2014


186) IL-17A Modulates Change of CTCs and Affects Metastases (Clinical Cancer Research) Friday May 30th 2014


187) Cross-Species Oral Carcinoma Genomic Analysis (Clinical Cancer Research) Friday May 30th 2014


188) CD14+ and PD1+ Prognostic in Follicular Lymphoma (Clinical Cancer Research) Friday May 30th 2014


189) CADM1 versus CD7 Plot in HTLV-I Disease Progression (Clinical Cancer Research) Friday May 30th 2014


190) Variants of Prostate Cancer (Clinical Cancer Research) Friday May 30th 2014


191) ALK1 and VEGF Inhibition: A Promising New Combination (Clinical Cancer Research) Friday May 30th 2014


192) Platinum Drug Immunogenicity (Clinical Cancer Research) Friday May 30th 2014


193) Analysis Plans in Phase III Trials with Biomarkers (Clinical Cancer Research) Friday May 30th 2014


194) Postmenopausal Bone Loss as Fuel for Metastatic Cancer (Clinical Cancer Research) Friday May 30th 2014


195) P95 Cutoff Confirmation in Trastuzumab-Treated Breast Cancer (Clinical Cancer Research) Friday May 16th 2014


196) Ficlatuzumab in Solid Tumor Patients with Liver Metastases (Clinical Cancer Research) Friday May 16th 2014


View: prev | next

#RealTimeChem:

Announcements:


Mitch Andre Garcia's Chem Feeds 2008-present

Some images have been reproduced by permission of The Royal Society of Chemistry. (RSC' RSS Policy)
Other images have been reproduced with permission of the American Chemical Society. (ACS' RSS Policy)
Few images have been reproduced with pending permission of Wiley-VCH. ()